Incidence and Characteristics of Multiple Primary Cancers: A 20-Year Retrospective Study of a Single Cancer Center in Korea

Jin-Hee Kwon,Heyjin Kim,Jin Kyung Lee,Young Jun Hong,Hye Jin Kang,Yoon Jung Jang

DOI: https://doi.org/10.3390/cancers16132346

2024-06-27

Cancers

Abstract:Rising cancer survival rates have led to an increased risk of multiple primary cancers (MPCs). Data on MPCs in South Korea are limited. This study aimed to address incidence and clinical characteristics of MPCs in a single cancer center in Korea during a 20-year period. We retrospectively analyzed 96,174 cancer patients at the Korea Cancer Center Hospital between 2003 and 2022, identifying 2167 patients with metachronous MPCs based on Surveillance, Epidemiology, and End Results SEER criteria. We categorized patients by cancer type (15 major solid cancer groups and 3 major hematologic cancer groups), including pathological diagnosis, assessed latency periods, and relative risks (RRs) for developing MPCs. The overall MPC incidence was 2.3%. Breast cancer (15.7%) was the most common primary cancer, and lung cancer (15.2%) was the most frequent second primary cancer. The median latency period for second primary cancers was 4.1 years. Decreasing latency periods for third and fourth primary cancers were observed (2.1 years and 1.6 years, respectively). Most cancers maintained their dominant pathological type despite notable changes in the prevalence of specific pathologies for certain types of second primaries. Lymphoma showed the highest RR (2.1) for developing MPCs. Significant associations were found between specific primary and subsequent cancers, including breast–ovary, thyroid–breast, stomach–pancreas, colorectal–head and neck, lung–prostate, and lymphoma–myeloid neoplasms. These findings contribute to a better understanding of MPC occurrence. They can inform future research on their etiology and development of improved management strategies.

oncology

What problem does this paper attempt to address?

This paper aims to address the incidence and clinical characteristics of multiple primary cancers (MPCs) in South Korea. Specifically, the study identifies 2,167 patients with metachronous multiple primary cancers from a retrospective analysis of data from 96,174 cancer patients at the Korea Cancer Center Hospital (KCCH) between 2003 and 2022, to explore the following aspects:

1. **Overall incidence of multiple primary cancers**: The study found that the overall incidence of multiple primary cancers was 2.3%.

2. **Most common types of first and second primary cancers**: Breast cancer was the most common first primary cancer (15.7%), while lung cancer was the most common second primary cancer (15.2%).

3. **Latency periods between different primary cancers**: The median latency period for second primary cancers was 4.1 years, while the latency periods for third and fourth primary cancers were 2.1 years and 1.6 years, respectively.

4. **Associations between specific primary cancers and subsequent cancers**: The study identified several significant associations, such as breast cancer with ovarian cancer, thyroid cancer with breast cancer, stomach cancer with pancreatic cancer, colorectal cancer with head and neck cancer, lung cancer with prostate cancer, and lymphoma with bone marrow tumors.

5. **Relative risk (RR)**: Lymphoma had the highest relative risk (2.1), indicating a higher risk of developing multiple primary cancers.

These findings contribute to a better understanding of the mechanisms of multiple primary cancers and provide a basis for future etiological research and the development of management strategies.